Patents by Inventor Christopher Yu-Tai Yen

Christopher Yu-Tai Yen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reloadable hydrogel system for treating brain conditions
    Patent number: 11382983
    Abstract: A drug delivery system and methods of using such for delivering a peglyated therapeutic agent to brain. The drug delivery system may comprise an antibody, which binds polyethylene glycol (PEG), wherein the antibody is embedded in a hydrogel, which may comprises one or more biodegradable polymers, up to 60% of which contain inter-chain or intra-chain covalent crosslinks. The amount of the antibody in the drug delivery system can be about 1-2 ?g per ?l of the hydrogel.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: July 12, 2022
    Assignee: ACADEMIA SINICA
    Inventors: Patrick C. H. Hsieh, David Lundy, Christopher Yu-Tai Yen
  • Reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction
    Patent number: 11135164
    Abstract: A drug delivery system and methods of using such for delivering a peglyated therapeutic agent to heart. The drug delivery system may comprise an antibody embedded in a hydrogel, comprising one or more biodegradable polymers, up to about 60% of which contain inter-chain or intra-chain covalent crosslinks.
    Type: Grant
    Filed: January 12, 2018
    Date of Patent: October 5, 2021
    Assignee: ACADEMIA SINICA
    Inventors: Patrick C. H. Hsieh, David Lundy, Christopher Yu-Tai Yen
  • RELOADABLE HYDROGEL SYSTEM FOR TREATING MYOCARDIAL INFARCTION
    Publication number: 20200121596
    Abstract: A drug delivery system and methods of using such for delivering a peglyated therapeutic agent to heart. The drug delivery system may comprise an antibody embedded in a hydrogel, comprising one or more biodegradable polymers, up to about 60% of which contain inter-chain or intra-chain covalent crosslinks.
    Type: Application
    Filed: January 12, 2018
    Publication date: April 23, 2020
    Applicant: Academia Sinicia
    Inventors: Patrick C.H. Hsieh, David Lundy, Christopher Yu-Tai Yen
  • IMPROVED RELOADABLE HYDROGEL SYSTEM FOR TREATING BRAIN CONDITIONS
    Publication number: 20200121799
    Abstract: A drug delivery system and methods of using such for delivering a peglyated therapeutic agent to brain. The drug delivery system may comprise an antibody, which binds polyethylene glycol (PEG), wherein the antibody is embedded in a hydrogel, which may comprises one or more biodegradable polymers, up to 60% of which contain inter-chain or intra-chain covalent crosslinks. The amount of the antibody in the drug delivery system can be about 1-2 ?g per ?l of the hydrogel.
    Type: Application
    Filed: January 12, 2018
    Publication date: April 23, 2020
    Applicant: Academia Sinica
    Inventors: Patrick C.H. Hsieh, David Lundy, Christopher Yu-Tai Yen